Recombinant human DRG2 protein; Source: E. coli derived, PGEX-4T; Tag: GST; Domain: 1-364 aa of BC000493
Conjugate
Unconjugated
Applications
Application Notes
WB: 1:3000-1:8000 IP: 0.5-4.0 μg for 1.0-3.0 mg of total protein lysate IHC: 1:50-1:500 IF/ICC: 1:50-1:500
General Notes
This product (Catalog No. DPABH-23136) is a rabbit-derived polyclonal antibody raised against human DRG2, targeting the amino acid region 1–364 of the protein. This antibody exhibits cross-reactivity with Human DRG2 from mouse and rat. It has been affinity purified by Protein A. Developmentally regulated GTP-binding protein (DRG) is a new subfamily within the superfamily of GTP-binding proteins. Its expression is regulated during embryonic development. DRG2 plays a critical role in control of the cell cycle and apoptosis (PMID:27669826, PMID:14759600). DRG2 Regulates G2/M Progression via the Cyclin B1-Cdk1 Complex. DPABH-23136 is suitable for use in Western blot (WB) (1:3,000–1:8,000), IP (0.5-4.0 μg for 1.0-3.0 mg of total protein lysate), IHC (1:50–1:500), IF/ICC (1:50–1:500) applications. DPABH-23136 is supplied as a liquid formulation in PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. For long-term storage, keep at −20 °C. For short-term use, store at 2–8 °C. Avoid repeated freeze–thaw cycles to maintain antibody integrity and performance.
My Review for Rabbit Anti-Human DRG2 (a.a. 1-364) Polyclonal antibody
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.